Abstract | OBJECTIVES: DESIGN: Forty-one (41) patients with a diagnosis of FMS and/or CFS were given D-ribose, a naturally occurring pentose carbohydrate, at a dose of 5 g t.i.d. for a total of 280 g. All patients completed questionnaires containing discrete visual analog scales and a global assessment pre- and post- D-ribose administration. RESULTS:
D-ribose, which was well-tolerated, resulted in a significant improvement in all five visual analog scale (VAS) categories: energy; sleep; mental clarity; pain intensity; and well-being, as well as an improvement in patients' global assessment. Approximately 66% of patients experienced significant improvement while on D-ribose, with an average increase in energy on the VAS of 45% and an average improvement in overall well-being of 30% (p < 0.0001). CONCLUSIONS:
|
Authors | Jacob E Teitelbaum, Clarence Johnson, John St Cyr |
Journal | Journal of alternative and complementary medicine (New York, N.Y.)
(J Altern Complement Med)
Vol. 12
Issue 9
Pg. 857-62
(Nov 2006)
ISSN: 1075-5535 [Print] United States |
PMID | 17109576
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
|
Topics |
- Activities of Daily Living
- Adult
- Dose-Response Relationship, Drug
- Fatigue Syndrome, Chronic
(drug therapy)
- Female
- Fibromyalgia
(drug therapy)
- Humans
- Middle Aged
- Pain Measurement
(methods)
- Patient Satisfaction
(statistics & numerical data)
- Pilot Projects
- Quality of Life
- Ribose
- Surveys and Questionnaires
- Treatment Outcome
|